| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00117-013-2547-9 |
| P698 | PubMed publication ID | 24500247 |
| P50 | author | Maximilian Reiser | Q15439977 |
| Konstantin Nikolaou | Q35704652 | ||
| Axel Rominger | Q102011091 | ||
| P2093 | author name string | A Graser | |
| C C Cyran | |||
| P M Kazmierczak | |||
| P2860 | cites work | Cancers of unknown primary origin: current perspectives and future therapeutic strategies | Q21245496 |
| The role of magnetic resonance imaging in the diagnosis and management of prostate cancer | Q26849794 | ||
| Cancer of unknown primary site | Q28261809 | ||
| Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. | Q30670924 | ||
| Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. | Q33509936 | ||
| Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis | Q33629309 | ||
| The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer? | Q33848437 | ||
| Diagnostic and therapeutic management of cancer of an unknown primary | Q35212598 | ||
| Carcinoma of unknown primary: key radiological issues from the recent National Institute for Health and Clinical Excellence guidelines | Q36326240 | ||
| A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network. | Q36737583 | ||
| Forty years experience of treating cancer of unknown primary | Q36846898 | ||
| Carcinoma of unknown primary (CUP). | Q37314820 | ||
| MRI of the prostate: clinical relevance and emerging applications | Q37833011 | ||
| Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin | Q40461000 | ||
| Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology | Q43129916 | ||
| Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging | Q43142308 | ||
| Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer | Q43478685 | ||
| Potential use of contrast-enhanced ultrasound (CEUS) in the detection of metastatic superficial lymph nodes in melanoma patients | Q43486089 | ||
| Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor | Q44045051 | ||
| Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. | Q44539388 | ||
| Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology | Q44705082 | ||
| Search for a primary lung neoplasm in patients with brain metastasis: is the chest radiograph sufficient? | Q48722330 | ||
| Value of ultrasound in detecting central compartment lymph node metastases in differentiated thyroid carcinoma. | Q50789823 | ||
| Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis. | Q50944619 | ||
| [Ultrasound in oncology: screening and staging]. | Q51179795 | ||
| Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. | Q53098703 | ||
| MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT). | Q53438988 | ||
| [Metastatic cáncer presentation. Validation of a diagnostic algorithm with 221 consecutive patients] | Q53676894 | ||
| Utility of Breast Magnetic Resonance Imaging in Patients With Occult Primary Breast Cancer | Q59481429 | ||
| Is Mammography of Value in Women with Disseminated Cancer of Unknown Origin? | Q59706453 | ||
| Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets | Q69409099 | ||
| Cancer of unknown primary site | Q71987789 | ||
| Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients | Q72504273 | ||
| Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992 | Q77569056 | ||
| Breast MR imaging in patients with axillary node metastases and unknown primary malignancy | Q78073250 | ||
| Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions | Q81356128 | ||
| High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system | Q81521034 | ||
| Clinical utility and prospective comparison of ultrasonography and computed tomography imaging in staging of neck metastases in head and neck squamous cell cancer in an Indian setup | Q84364711 | ||
| Detection of underlying malignancy in patients with paraneoplastic neurological syndromes: comparison of 18F-FDG PET/CT and contrast-enhanced CT | Q86413841 | ||
| Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? | Q86455875 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 117-123 | |
| P577 | publication date | 2014-02-01 | |
| P1433 | published in | Radiologe | Q15763177 |
| P1476 | title | [Radiological diagnostics in CUP syndrome] | |
| P478 | volume | 54 |
| Q36228314 | 68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer |
| Q52980637 | The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin. |
Search more.